Huge congratulations to
@samiinkinen
and team
@virtahealth
for raising a $65M Series D round, led by
@sequoia
to fuel growth for their life-changing reversal treatment for type 2 diabetes & other metabolic diseases. The company is now valued at $1B 🚀
Proud to announce Virta's $65M Series D, led by our partners at
@sequoia
- this means even faster scaling of our T2 diabetes reversal treatments for the benefit of millions of patients & payers nationwide. Still Day One
@virtahealth
- much more to come!